BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| 1 |
Apple
AAPL
|
+$1.2B |
| 2 |
iShares MSCI ACWI ETF
ACWI
|
+$981M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$944M |
| 4 |
SPDR S&P Biotech ETF
XBI
|
+$873M |
| 5 |
Microsoft
MSFT
|
+$816M |
Top Sells
| 1 |
Home Depot
HD
|
+$243M |
| 2 |
Fiserv
FI
|
+$152M |
| 3 |
American Tower
AMT
|
+$144M |
| 4 |
Tesla
TSLA
|
+$138M |
| 5 |
Uber
UBER
|
+$112M |
Sector Composition
| 1 | Technology | 19.65% |
| 2 | Financials | 12.31% |
| 3 | Consumer Discretionary | 8.67% |
| 4 | Healthcare | 6.81% |
| 5 | Communication Services | 6.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2976
GSI Technology
GSIT
$87.6M
| $37.9K | ﹤0.01% |
5,666
+1,753
| +45% | +$11.7K |
|
2977
CoreCard
CCRD
$208M
| $37.8K | ﹤0.01% |
925
-480
| -34% | -$19.6K |
|
2978
Applied Therapeutics
APLT
$64M
| $37.8K | ﹤0.01% |
2,017
-535
| -21% | -$10K |
|
2979
InfuSystem Holdings
INFU
$206M
| $37.8K | ﹤0.01% |
1,855
-889
| -32% | -$18.1K |
|
|
ORGS
2980
DELISTED
Orgenesis Inc. Common Stock
ORGS
| $37.3K | ﹤0.01% |
650
+343
| +112% | +$19.7K |
|
2981
Co-Diagnostics
CODX
$11.8M
| $37.2K | ﹤0.01% |
3,899
-3,157
| -45% | -$30.1K |
|
2982
First Guaranty Bancshares
FGBI
$126M
| $37.2K | ﹤0.01% |
2,283
+708
| +45% | +$11.5K |
|
|
EIGR
2983
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
| $37K | ﹤0.01% |
139
-71
| -34% | -$18.9K |
|
2984
Novo Nordisk
NVO
$242B
| $37K | ﹤0.01% |
1,098
+202
| +23% | +$6.81K |
|
2985
PAVmed
PAVM
$9.29M
| $36.7K | ﹤0.01% |
551
+94
| +21% | +$6.26K |
|
2986
LifeVantage
LFVN
$143M
| $36.5K | ﹤0.01% |
3,904
+1,390
| +55% | +$13K |
|
2987
Abeona Therapeutics
ABEO
$335M
| $35.9K | ﹤0.01% |
764
+315
| +70% | +$14.8K |
|
|
HARP
2988
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $35.6K | ﹤0.01% |
170
-28
| -14% | -$5.87K |
|
2989
KALA BIO
KALA
$107M
| $34.8K | ﹤0.01% |
103
-89
| -46% | -$30.1K |
|
|
CURO
2990
DELISTED
CURO Group Holdings Corp.
CURO
| $34.7K | ﹤0.01% |
2,379
-2,539
| -52% | -$37K |
|
|
QTNT
2991
DELISTED
Quotient Limited Ordinary Shares
QTNT
| $34.7K | ﹤0.01% |
236
-110
| -32% | -$16.2K |
|
|
AXDX
2992
DELISTED
Accelerate Diagnostics
AXDX
| $34.6K | ﹤0.01% |
416
-289
| -41% | -$24.1K |
|
|
ASAP
2993
DELISTED
Waitr Holdings Inc. Common Stock
ASAP
| $34.3K | ﹤0.01% |
586
-218
| -27% | -$12.8K |
|
2994
iShares MSCI Italy ETF
EWI
$718M
| $34.3K | ﹤0.01% |
1,089
+41
| +4% | +$1.29K |
|
2995
iShares Global Energy ETF
IXC
$1.85B
| $34.2K | ﹤0.01% |
1,389
| – | – |
|
2996
Pangaea Logistics
PANL
$353M
| $33.9K | ﹤0.01% |
10,741
+662
| +7% | +$2.09K |
|
2997
TechnipFMC
FTI
$16.8B
| $33.7K | ﹤0.01% |
4,369
-135,071
| -97% | -$1.04M |
|
2998
Hamilton Beach Brands
HBB
$193M
| $33.4K | ﹤0.01% |
1,844
+551
| +43% | +$9.99K |
|
|
AGFS
2999
DELISTED
AgroFresh Solutions, Inc. Common Stock
AGFS
| $33.3K | ﹤0.01% |
16,664
+6,046
| +57% | +$12.1K |
|
3000
Unilever
UL
$154B
| $32.9K | ﹤0.01% |
590
-4,120
| -87% | -$230K |
|